Codagenix Announces BARDA Contract for Project NextGen Supporting Development of CoviLiv™ as an Intranasal COVID-19 Vaccine
- Tuesday, October 3, 2023, 7:03
- Finance
- Add a comment
Agreement is part of the U.S. Department of Health and Human Services’ Project NextGen and will provide an initial $10 million and up to $389 million to cover costs for a 10,000-volunteer Phase 2b clinical study of CoviLiv evaluated against an authorized mRNA XBB.1.5 comparator vaccine in…
About the Author
adminasapcorp has written 39016 stories on this site.